Worldwide Prescription Drug Sales in 2024: Top 10 Companies part 2 of 2 Table 3: Worldwide Prescription Drug Sales (2018-2024): Top 10 Companies & Total Market Source: EvaluatePharma, May 2019 WW Prescription Sales ($bn) WW Market Share Rank Rank Company 2018 2024 CAGR 2018 2024 Chg. (+/-) Chg. (+/-) 1. P昀椀zer 45.3 51.2 +2.1% 5.5% 4.3% -1.1pp +0 2. Novartis 43.5 49.8 +2.3% 5.3% 4.2% -1.0pp +1 3. Roche 44.6 46.7 +0.8% 5.4% 4.0% -1.4pp -1 4. Johnson & Johnson 38.8 45.8 +2.8% 4.7% 3.9% -0.8pp +0 5. Merck & Co 37.4 42.5 +2.2% 4.5% 3.6% -0.9pp +0 6. Sano昀椀 35.1 40.7 +2.5% 4.2% 3.4% -0.8pp +0 7. GlaxoSmithKline 30.6 38.7 +4.0% 3.7% 3.3% -0.4pp +1 8. AbbVie 32.1 35.0 +1.4% 3.9% 3.0% -0.9pp -1 9. Takeda 17.4 32.3 +10.8% 2.1% 2.7% +0.6pp +7 10. AstraZeneca 20.7 32.2 +7.7% 2.5% 2.7% +0.2pp +2 Total Top 10 345.4 414.8 +3.1% 41.7% 35.1% -6.6pp Other 482.3 766.0 +8.0% 58.3% 64.9% Total 827.8 1,180.8 +6.1% 100.0% 100.0% Note: Takeda acquired Shire on January 8th 2019 for $64.1bn, thus inheriting all of Shire’s forecast revenue. This accounts for the signi昀椀cant increase in Worldwide Prescription Drug Sales between 2018 and 2024. At the time of writing, Takeda 2018 prescription sales are based on a consensus of leading equity analysts’ estimates. 11 ® World Preview 2019 Copyright © 2019 Evaluate Ltd. All rights reserved. EvaluatePharma